Skip to main content
Premium Trial:

Request an Annual Quote

Alveo Technologies: Julianne Averill

Infectious disease diagnostic firm Alveo Technologies recently announced the appointment of Julianne Averill as CFO. She will be responsible for leading all financial operations and implementing strategies to accelerate Alveo's growth, the company said in a statement. Averill has 18 years of leadership experience and most recently served as VP of Finance for BlackThorn Therapeutics. Before that, she held leadership positions at Manifest MedEx and Starwood Waypoint Residential Trust and served as an audit manager at Deloitte. Averill has also participated in or led strategic financing and M&A initiatives totaling more than $2 billion. 

The Scan

Boosters Chasing Variants

The New York Times reports that an FDA advisory panel is to weigh updated booster vaccines for COVID-19.

Not Yet

The World Health Organization says monkeypox is not yet a global emergency, the Washington Post reports.

More Proposed for Federal Research

Science reports that US House of Representatives panels are seeking to increase federal research funding.

PLOS Papers on Breast Cancer Metastasis, Left-Sided Cardiac Defects, SARS-CoV-2 Monitoring

In PLOS this week: link between breast cancer metastasis and CLIC4, sequencing analysis of left-sided cardiac defects, and more.